In vitro evaluation of inhibitory effect of Phoenix dactylifera bark extract on rat lipid peroxidation and blood hemolysis
Purpose: To determine the polyphenolic content of P. dactylifera L. (date palm) bark extract and to investigate its in vitro inhibitory effects on lipid peroxidation in the brain, liver, and kidney tissues of rat, as well as on blood hemolysis in rats.
Methods: P. dactylifera L. barks were collected from Ahvaz, (Khuzestan, Iran). Methanolic extract of the P. dactylifera barks were prepared using maceration method. Total phenolic, flavonoid and proanthocyanidin contents were determined by colorimetric methods. The effects of the extract were investigated on thiobarbituric acid reactive substances formation in Fe2+/ascorbate induced-lipid
peroxidation in brain, liver and kidney tissues of rats. Furthermore, the inhibitory effects of the extracts on erythrocyte hemolysis caused by 2,2'-Azobis (2-amidinopropane) dihydrochloride (AAPH) were evaluated.
Results: Total phenolic, flavonoids and proanthocyanidins contents per each g dry extract of P. dactylifera L. were 50.7 mg tannic acid, 10.38 mg rutin, and 5.45 mg cyanidin, respectively, while halfmaximal inhibitory concentration (IC50) for inhibition of lipid peroxidation in brain, liver, and kidney tissues of rats was 3150.71, 1941.45, and 1546.01 μg/mL, respectively, and for the inhibition of erythrocyte hemolysis, it was 472.41 μg/mL.
Conclusion: The findings of this study indicate significant anti-lipid peroxidation and anti-hemolytic effects of the bark extract. Therefore, the extract can potentially be used for the in vivo treatment of diseases associated with lipid peroxidation such as cancers and Alzheimer's disease, but further studies are required.
Keywords: Phoenix dactylifera, Date palm, Lipid peroxidation, Antioxidant, Erythrocyte hemolysis
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.